Animal & Veterinary

Guidances Under Development for 2015

CVM Guidance Documents Under Development
(expected to publish as drafts or finals by the end of December 2015)

Introduction

The following list of guidance topics includes possible new topics for guidance documents or revisions to existing guidance documents that the CVM is considering. We currently intend to develop guidance on each topic; however, the Center is neither bound by this list of topics, nor required to issue every guidance document on this list. We are not precluded from developing guidance documents on topics not on this list.

CVM Guidance Documents Under Development list has been updated to include those documents expected to publish by the end of 2015.

Center for Veterinary Medicine
2015 Guidance Agenda

Title of GuidanceContact
Draft Guidance for Industry – Marketed Unapproved New Animal DrugsEric Nelson, Center for Veterinary Medicine, Food and Drug Administration, (HFV-), 7519 Standish Place, Rockville, MD 20855, 240-276-9200, eric.nelson@fda.hhs.gov
Draft Guidance for Industry – Compounding Animal Drugs from Bulk Drug SubstancesEric Nelson, Center for Veterinary Medicine, Food and Drug Administration, (HFV-), 7519 Standish Place, Rockville, MD 20855, 240-276-9200, eric.nelson@fda.hhs.gov
Guidance For Industry (GFI #61) - FDA Approval of Animal Drugs for Minor Uses and for Minor Species (Revision)Margaret Oeller, Center for Veterinary Medicine (HFV-50), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0566, margaret.oeller@fda.hhs.gov
Draft Guidance for Industry (GFI #210) – The Indexing of Legally Marketed Unapproved New Animal Drugs for Minor SpeciesMargaret Oeller, Center for Veterinary Medicine (HFV-50), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0566, margaret.oeller@fda.hhs.gov
Guidance for Industry (GFI #225) – Electronic Exchange of Documents: File Format Requirements – VICH GL53Scott Fontana, Center for Veterinary Medicine, (HFV-100), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0656, scott.fontana@fda.hhs.gov
Guidance for Industry (GFI #224) – Bioequivalence: Blood Level Bioequivalence Study – VICH GL52Marilyn Martinez, Center for Veterinary Medicine, (HFV-100), Food and Drug Administration, 7520 Standish Place, Rockville, MD 20855, 240-402-0635, marilyn.martinez@fda.hhs.gov
Draft Guidance for Industry – Combination New Animal DrugsHerman Schoenemann, Center for Veterinary Medicine, (HFV-108), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0652, herman.schoenemann@fda.hhs.gov
Guidance for Industry (GFI #218) – Cell-Based Products for Use in AnimalsLynne Boxer, Center for Veterinary Medicine, (HFV-114), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0611, lynne.boxer@fda.hhs.gov
Draft Guidance for Industry (GFI #228) – Designing Effectiveness Studies for Common Animal Production Indications (Growth, Feed Efficiency, Carcass Leanness, Reproduction, Milk Production)Amey Adams, Center for Veterinary Medicine, (HFV-126), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0816, amey.adams@fda.hhs.gov
Draft Guidance for Industry (GFI #229) - Evaluating the Effectiveness of New Animal Drugs for the Reduction of Pathogenic Shiga Toxin-Producing E. coli in CattleJoshua Hayes, Center for Veterinary Medicine, (HFV-133), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0585, joshua.hayes@fda.hhs.gov
Guidance for Industry (GFI #23) – Medicated Free Choice Feeds (Revision)Dennis Bensley, Center for Veterinary Medicine, (HFV-140), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0696, dennis.bensley@fda.hhs.gov
Draft Guidance for Industry – Medicated Feed AssaysDennis Bensley, Center for Veterinary Medicine, (HFV-140), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0696, dennis.bensley@fda.hhs.gov
Draft Guidance for Industry – Chemistry, Manufacturing and Controls (CMC) Guidances for Generic New Animal DrugsDennis Bensley, Center for Veterinary Medicine, (HFV-140), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0696, dennis.bensley@fda.hhs.gov
Draft Guidance for Industry – Development of In Vivo In Vitro Correlation (IVIVC) for Sustained Released Injectables (SRI)Gregory Hunter, Center for Veterinary Medicine, (HFV-142), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0675, gregory.hunter@fda.hhs.gov
Draft Guidance for Industry (GFI #57) – Preparation and Submission of Veterinary Master Files (Revision)Gregory Hunter, Center for Veterinary Medicine, (HFV-142), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0675, gregory.hunter@fda.hhs.gov
Draft Guidance for Industry – Question-Based Review for Animal DrugsJulie Bailey, Center for Veterinary Medicine, (HFV-145), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0700, julie.bailey@fda.hhs.gov
Guidance for Industry – Submitting Two-Phased Chemistry, Manufacturing and Controls (CMC) Technical SectionsHeather Longstaff, Center for Veterinary Medicine (HFV-145), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0651, heather.longstaff@fda.hhs.gov
Guidance for Industry (GFI #207) – Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food Producing Animals: Marker Residue Depletion Studies to Establish Product Withdrawal Periods – VICH GL48 (Revised)Julia Oriani, Center for Veterinary Medicine, (HFV-151), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0788, Julia.oriani@fda.hhs.gov
Guidance for Industry (GFI #208) – Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food Producing Animals: Validation of Analytical Methods used in Residue Depletion Studies – VICH GL49 (Revision)Julia Oriani, Center for Veterinary Medicine, (HFV-151), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0788, Julia.oriani@fda.hhs.gov
Guidance for Industry (GFI #116) – Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Genotoxicity Testing – VICH GL23(R)Tong Zhou, Center for Veterinary Medicine, (HFV-153), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0826, tong.zhou@fda.hhs.gov
Draft Guidance for Industry – Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Establish an Acute Reference Dose (ARfD) – VICH GL54Tong Zhou, Center for Veterinary Medicine, (HFV-153), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0826, tong.zhou@fda.hhs.gov
Draft Guidance for Industry – Presenting and Analyzing Target Animal Safety Study DataVirginia Recta, Center for Veterinary Medicine, (HFV-164), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0840, virginia.recta@fda.hhs.gov
Guidance for Industry (GFI #171) – Waivers of In Vivo Demonstration (Revision)John Harshman , Center for Veterinary Medicine, (HFV-170), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 240-402-0845, john.harshman@fda.hhs.gov
Draft Guidance for Industry – Proprietary Names on Drug LabelingTomislav Modric, Center for Veterinary Medicine (HFV-216), 7519 Standish Place, Food and Drug Administration, Rockville, MD 20855, 240-276-9078, tomislav.modric@fda.hhs.gov
Guidance for Industry (GFI #221) – Recommendations for Preparation and Submission of Animal Food Additive PetitionsSharon Benz, Center for Veterinary Medicine (HFV-220), Food and Drug Administration, 7519 Standish Place, Rockville, MD 20855, 240-453-6864, sharon.benz@fda.hhs.gov
Guidance for Industry (GFI #80) – Effectiveness Studies for Anti-Salmonella Animal Food Additives (Revision)Xin Li, Center for Veterinary Medicine (HFV-222), Food and Drug Administration, 7519 Standish Place, Rockville, MD 20855, 240-453-6863, xin.li@fda.hhs.gov
Draft Guidance for Industry – Design and Submission of Distributor LabelingNeal Bataller, Center for Veterinary Medicine (HFV-210), Food and Drug Administration, 7519 Standish Place, Rockville, MD 20855, 240-276-9062, neal.bataller@fda.hhs.gov  
Guidance for Industry (GFI #220) – Use of Nanomaterials in Food for AnimalsDragan Momcilovic, Center for Veterinary Medicine (HFV-226), Food and Drug Administration, 7519 Standish Place, Rockville, MD 20855, 240-453-6856, dragan.momcilovic@fda.hhs.gov
Draft Guidance for Industry (GFI #203) – Ensuring Safety of Animal Food Maintained and Fed On-FarmPhares Okelo, Center for Veterinary Medicine (HFV-226), 7519 Standish Place, Food and Drug Administration, Rockville, MD 20855, 240-453-6862, phares.okelo@fda.hhs.gov  
Compliance Policy Guide – Labeling and Marketing of Dog and Cat Food Products Intended to Diagnose, Cure, Mitigate, Treat, or Prevent DiseasesWilliam Burkholder, Center for Veterinary Medicine (HFV-228), Food and Drug Administration, 7519 Standish Place, Rockville, MD 20855, 240-453-6865, william.burkholder@fda.hhs.gov
Draft Guidance for Industry - Manufacturing, Processing, or Holding Active Pharmaceutical IngredientsJonathan Bray, Center for Veterinary Medicine (HFV-232), 7519 Standish Place, Food and Drug Administration, Rockville, MD 20855, 240-276-9226, jonathan.bray@fda.hhs.gov

 

Page Last Updated: 02/02/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.